National brain tumour research funding needs to increase to £35 million a year
Brain tumour patients and COVID-19 vaccines survey
The International Brain Tumour Alliance (IBTA) is running a new survey on COVID-19 vaccines and brain tumour patients.
The survey is for people over the age of 18 who have been diagnosed with any type of brain tumour (including metastatic brain tumours). It will collect data anonymously on, for example, how the coronavirus vaccination programmes in different countries have been offered to brain tumour patients; COVID-19 testing; which vaccines brain tumour patients have received; and vaccine side effects in brain tumour patients.
The survey typically takes no more than 10 minutes to complete and the deadline for submitting survey responses is 31st August 2021.
To access the survey to take part, please use this direct link: www.research.net/r/IBTACOVIDVAX
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.